Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IV t-PA in Wake-up Stroke
NCT01183533Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jul 2010
- Primary completion
- Oct 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in ischemic stroke, sponsored by UTHealth Houston. Started Jul 2010; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01183533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01183533.